Articles by Larissa Ku
CICC raises $229m for China healthcare fund
China's CICC Capital has raised RMB1.6 billion ($229 million) for its first fund dedicated to the biopharmaceutical space.
Chinese fashion design platform raises $14m
Linctex Digital, a Shanghai-based design services platform for the fashion industry, has raised RMB100 million ($14 million) in funding led by Gaorong Capital. Shunwei Capital, Vision Plus Capital, Baidu Ventures and Yinxinggu Capital also took part....
Chinese online insurance player raises $55m in US IPO
Huize Holding, a Shanghai-based insurance platform backed by SAIF Partners, has raised about $55 million in a US IPO.
China B2B platform Yijiupi raises new round, buys Zskuaixiao
Yijiupi, a Chinese B2B e-commerce platform that initially focused on liquor products, has acquired local B2B consumer goods distributor Zskuaixiao. It has also secured a new round of funding backed by several Zskuaixiao investors.
Chinese medical imaging business secures $86m Series B
Shanghai-based Universal Medical Imaging, China’s largest independent imaging diagnosis company has raised a RMB600 million ($86 million) Series B round led by Cathay Capital, V Star Capital and CEC Capital.
Schroders backs Singapore incubator Antler
Schroders has participated in a funding round for Singapore-headquartered incubator Antler that takes the company's total fundraising over the past six months to $75 million.
Deal focus: Lightspeed targets solid-state LiDAR
Having assessed some 40 autonomous driving companies globally, Lightspeed China Partners decided that Hesai - a business born in the US and raised in China - is best-placed to take the technology forwards
PE-backed Akeso Biopharma targets Hong Kong IPO
Chinese biotech player Akeso Biopharma has made a second attempt at filing for a Hong Kong IPO after its previous application was rejected last month for failing to meet regulatory requirements.
Japan's SBI seeks $920m for technology fund
SBI Investment has launched a technology-focused VC fund, known as 4+5 Fund, with a target of JPY100 billion ($920 million).
AVCJ Awards 2019: Deal of the Year - Small Cap: AffaMed Therapeutics
CBC Group established biosimilars specialist AffaMed Therapeutics to remove uncertainties in the development process and to tap Chinese demand for affordable treatments
Joy Capital leads $88m round for China's Shihuituan
Joy Capital has announced its participation - as the lead investor - in an $88.3m funding round for Chinese community group buying platform Shihuituan, which is also known as Nice Tuan.
Chinese genetic testing player for infectious diseases gets Series B+
Chinese genetic testing specialist Genskey raised an RMB50 million ($7.1m) extended Series B round of funding led by Shenzhen-based Fortune Capital. Existing investor Legend Capital re-upped.
Raffles Family Office backs Hong Kong co-working space player
Hong Kong-based multi-family office Raffles Family Office will invest $15 million in local co-working space operator WorkTech.
Centurium leads $100m Series D for China's Yunxuetang
Yunxuetang, an online corporate training services provider focused on China, has raised $100 million in Series D funding led by Centurium Capital. Existing investors Yunfeng Capital and SIG both re-upped.
Warburg Pincus returns $2b from China portfolio in 2019
Warburg Pincus generated distributions of $2 billion from its China investments last year, a record annual total for its local operation.
Profile: Joy Capital's Erhai Liu
First at Legend Capital and now at Joy Capital, Erhai Liu has demonstrated a knack for spotting emerging technology trends in China and helping founders navigate the challenges of entrepreneurialism
Green Pine leads Series B for Chinese gene testing player
Chinese gene testing business AmCare Genomics Lab has raised RMB110 million ($16 m) in Series B funding led by Green Pine Capital Partners. This comes four months after the company closed an extended Series A round of RMB30 million.
Centurium backs China logistics player
Centurium Capital has invested $300 million in ANE Logistics, one of the largest LTL (Less-than-truckload) operators in China.
AVCJ Awards 2019: Deal of the Year - Mid Cap: Hangzhou UCO Cosmetics
CITIC Capital’s acquisition of Hangzhou UCO Cosmetics was predicated on the rise of China’s beauty industry, but it is also part of a broader ecosystem play
LPs want to see how GPs learn from mistakes in Asia
GPs should be open and transparent with LPs about their previous difficulties in order to demonstrate an ability to learn from past mistakes, the Hong Kong Venture Capital & Private Equity Association’s (HKVCA) Asia Forum heard.
Chinese 3D map provider raises $14m
Airlook, a Chinese three-dimensional map provider, has raised nearly RMB100 million ($14 million) in an extended Series B round led by GF Qianhe, the alternative investment arm of Hong Kong-listed GF Securities.
Deal focus: Baibu broadens its fabric scope
VC-backed Chinese B2B fabrics trading platform Baibu is making the transition from online marketplace to cloud-based consolidator of the country's fragmented factories
Discipline, operations key to PE success in China - DCP's Liu
Private equity investors in China should prioritize discipline on valuations and operational capabilities rather than spend their time worrying about macroeconomic risks, according to David Liu, chairman and founder of DCP Capital.
GIC, ESR team up on $500m China venture
ESR, an Asia Pacific-focused logistics real estate platform, has formed a joint venture with Singapore’s GIC Private with a view to investing $500 million in high-quality facilities in China.